Fibrinolysis and its management in cardiac surgery
Fibrinolýza v kardiochirurgii a možnosti jejího ovlivnění
Práce shrnuje současné poznatky o fibrinolýze a antifibrinolytikách v kardiochirurgii. Zabývá se efektivitou a bezpečností antifibrinolytické léčby u kardiochirurgických operací s použitím mimotělního oběhu a u operací „na bijícím srdci“.
Klíčová slova:
kardiochirurgie – fibrinolýza – aprotinin – tranexamová kyselina
Authors:
T. Vaněk; J. Šnircová
Authors‘ workplace:
Kardiochirurgická klinika 3. LF UK a FNKV, Praha
Published in:
Anest. intenziv. Med., 18, 2007, č. 5, s. 282-285
Category:
Anaesthesiology - Review Article
Overview
The article summarizes current knowledge of fibrinolysis and fibrinolytic inhibitors in cardiac surgery. It deals with the effectiveness and safety of antifibrinolytic therapy in “on-pump” and “off-pump” cardiac surgery.
Key words:
cardiac surgery – fibrinolysis – aprotinin – tranexamic acid
Labels
Anaesthesiology, Resuscitation and Inten Intensive Care MedicineArticle was published in
Anaesthesiology and Intensive Care Medicine
2007 Issue 5
Most read in this issue
- Cardiogenic shock and its current management options
- Professor Peter J. Safar, MD (1924–2003): unbelievable life career
- Fibrinolysis and its management in cardiac surgery
- Fast-track and ultra fast-track cardiac anaesthesia – postoperative pain and other parameters observation